Cook Medical has announced the launch of a new otolaryngology/head and neck surgery clinical division, according to a news release.
Cook OHNS will focus on researching and developing alternatives to open surgery for treating ENT conditions, according to the company. OHNS will initially focus on soft tissue repair, salivary gland disease, chronic sinusitis, vocal cord paralysis, obstructive sleep apnea, and interventional airway and esophageal procedures.
Cook recently unveiled OHNS and a selection of its current and upcoming products at the American Academy of Otolaryngology-Head and Neck Surgery conference. Products included salivary duct access tools, stone extractor set, Biodesign dural advanced tissue graft and the Chiba EchoTip biopsy needle.
"We started Cook OHNS to pioneer ways to provide patients with diseases affecting the head and neck with less traumatic alternatives to surgeries," said Thomas Cherry, global leader for Cook Medical's OHNS division, in the release. "As we met with physicians, we heard loud and clear that they saw many opportunities for minimally invasive medical devices in this field. At our core, we've always solved problems for clinicians over Cook's entire history. So now, Cook OHNS is taking proven interventional tools and techniques and applying them to the emerging science of minimally invasive otolaryngology and head and neck surgery."
Cook Medical's U.S. headquarters is in Bloomington, Ind.
Related Articles on New Technology:
SinuSys Completes FDA Submission for Sinus Dilation System
Siemens Receives FDA Clearance for Digital Radiography System
Q Urological Set to Launch Pediatric Ureteral Stent